The rate of muscle wasting in liver transplant recipients on waiting list: post-transplant outcomes and associated serum metabolite patterns

dc.contributor.authorRokop, Zachary P.
dc.contributor.authorO’Connell, Thomas M.
dc.contributor.authorMunsch, Taylor
dc.contributor.authorNephew, Lauren
dc.contributor.authorOrman, Eric
dc.contributor.authorMihaylov, Plamen
dc.contributor.authorMangus, Richard S.
dc.contributor.authorKubal, Chandrashekhar
dc.contributor.departmentSurgery, School of Medicine
dc.date.accessioned2025-01-22T14:01:20Z
dc.date.available2025-01-22T14:01:20Z
dc.date.issued2024
dc.description.abstractBackground: Sarcopenia at the time of liver transplantation (LT) is an established risk factor for mortality following LT. However, most studies in this context have defined sarcopenia by one-time, static measurements. The aims of this study were (I) to determine the impact of the rate of muscle loss in waitlisted LT recipients on post-LT outcomes and (II) to identify patterns of serum metabolites associated with patients with more progressive sarcopenia. Methods: Patients undergoing liver transplant from 2008 to 2018 who received more than one computed tomography (CT) scans within 12 months prior to liver transplant were included (n=61). The psoas muscle index (PMI) was calculated using Slice-O-Matic software and corrected for patient height (m2). Patients were classified into two groups based the rate of reduction in PMI-high wasting [HW; change in PMI (ΔPMI) ≤-1%/month] and low wasting (LW; ΔPMI >-1%/month). Pre-transplant serum metabolic profiles were collected using nuclear magnetic resonance (NMR) spectroscopy. Living kidney donor sera was used as healthy controls. Results: Median ΔPMI was -2.0%/month in HW and -0.15%/month in LW patients (P<0.001). Post-transplant 1-year mortality was significantly higher in HW patients. There were no significant differences in metabolite concentrations between HW and LW patients. However, perturbations in taurine, sarcosine, betaine and the aromatic amino acids (AAAs), were observed in patients with liver disease as compared to healthy controls. Liver disease was also associated with a decrease in lipoprotein profiles, especially high-density lipoprotein (HDL) particles. Conclusions: In patients undergoing LT, the rate of progression of sarcopenia is a strong prognostic indicator of post-LT death. Serum metabolite profiles were not characteristically unique to HW patients, and most closely resemble derangements associated with chronic liver disease.
dc.eprint.versionFinal published version
dc.identifier.citationRokop ZP, O'Connell TM, Munsch T, et al. The rate of muscle wasting in liver transplant recipients on waiting list: post-transplant outcomes and associated serum metabolite patterns. Hepatobiliary Surg Nutr. 2024;13(6):962-973. doi:10.21037/hbsn-23-645
dc.identifier.urihttps://hdl.handle.net/1805/45370
dc.language.isoen_US
dc.publisherAME
dc.relation.isversionof10.21037/hbsn-23-645
dc.relation.journalHepatobiliary Surgery and Nutrition
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.sourcePMC
dc.subjectLiver transplantation (LT)
dc.subjectMetabolome
dc.subjectPsoas muscle index (PMI)
dc.subjectSarcopenia
dc.titleThe rate of muscle wasting in liver transplant recipients on waiting list: post-transplant outcomes and associated serum metabolite patterns
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Rokop2024Rate-CCBYNCND.pdf
Size:
438.04 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: